Citation: D. Machin, ASSESSING QUALITY-OF-LIFE IN COMPARATIVE CANCER CLINICAL-TRIALS - DOES IT MAKE A DIFFERENCE, Controlled clinical trials, 18(4), 1997, pp. 301-305
Authors:
SOUHAMI RL
CRAFT AW
VANDEREIJKEN JW
NOOIJ M
SPOONER D
BRAMWELL VHC
WIERZBICKI R
MALCOLM AJ
KIRKPATRICK A
USCINSKA BM
VANGLABBEKE M
MACHIN D
Citation: Rl. Souhami et al., RANDOMIZED TRIAL OF 2 REGIMENS OF CHEMOTHERAPY IN OPERABLE OSTEOSARCOMA - A STUDY OF THE EUROPEAN OSTEOSARCOMA INTERGROUP, Lancet, 350(9082), 1997, pp. 911-917
Citation: P. Yuen et al., GEOGRAPHICAL VARIATION IN THE STANDARDIZED YEARS OF POTENTIAL LIFE LOST RATIO (SYPLR) IN WOMEN DYING FROM MALIGNANCIES OF THE BREAST IN ENGLAND AND WALES, British Journal of Cancer, 75(7), 1997, pp. 1069-1074
Citation: D. Machin, MORBO, PERSONHOOD, AND THE ABSENCE OF A SENSATIONALIST PRESS IN SPAIN+ TABLOID NEWSPAPERS, MORBID CURIOSITY, AND AN ETHNOGRAPHIC STUDY IN VALENCIA, Journal of Mediterranean Studies, 6(2), 1996, pp. 247-255
Citation: M. Staquet et al., GUIDELINES FOR REPORTING RESULTS OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS, Quality of life research, 5(5), 1996, pp. 496-502
Authors:
VERNON CC
HAND JW
FIELD SB
MACHIN D
WHALEY JB
VANDERZEE J
VANPUTTEN WLJ
VANRHOON GC
VANDIJK JDP
GONZALEZ DG
LIU FF
GOODMAN P
SHERAR M
Citation: Cc. Vernon et al., RADIOTHERAPY WITH OR WITHOUT HYPERTHERMIA IN THE TREATMENT OF SUPERFICIAL LOCALIZED BREAST-CANCER - RESULTS FROM 5 RANDOMIZED CONTROLLED TRIALS, International journal of radiation oncology, biology, physics, 35(4), 1996, pp. 731-744
Citation: T. Colton et al., PAPERS FROM THE INTERNATIONAL MEETINGS OF THE INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS - PREFACE, Statistics in medicine, 15(24), 1996, pp. 2633-2633
Citation: Rj. Stephens et al., LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - THE CASE FOR A STANDARD DEFINITION, Lung cancer, 15(3), 1996, pp. 297-309
Citation: D. Machin et M. Carrithers, FROM INTERPRETATIVE COMMUNITIES TO COMMUNITIES OF IMPROVISATION, Media, culture & society, 18(2), 1996, pp. 343-352
Authors:
GIRLING DJ
THATCHER N
CLARK PI
HOPWOOD P
TWIDDY S
STEPHENS RJ
BAILEY AJ
MACHIN D
BLEEHEN NM
BOLGER JJ
CONNOLLY CK
HASLETON PS
MACBETH FR
MOGHISSI K
SAUNDERS MI
WHITE RJ
ALCOCK S
BURT H
CROSSLEY E
DECKER E
ENGLISH J
FOSTER G
HANNIGAN K
HERON D
HUTCHINSON J
LOMAX L
MERCER V
PAGE S
ROTHWELL T
STAINES K
TAYLORNEAL P
TURNBALL V
AXFORD AT
EARL HM
GLAHOLM J
FALK SJ
GRAHAM JD
JONES DK
COOMBES RC
EPSTEIN RJ
HANHAM I
LOWDELL CP
NEWLANDS E
SMITH DB
COOKSON JB
ANDERSON H
GRIBBIN HR
SINCLAIR DJM
CARMICHAEL J
CHAN SYT
JOHNSTON IDA
MORGAN SA
DUNN KS
MANIFOLD IH
RADSTONE DJ
LAMONT A
ROBINSON ACR
BISSETT D
NICOLSON MC
TANG OT
SINNAMON DG
VARGHESE G
BIBBY RJ
OREILLY JF
BATH JCJ
BREDIN CP
STEWART SJ
WHILLIS D
WILTSHIRE CR
MCILLMURRAY MB
BOND MG
WARDMAN AG
BOZZINO JM
FERGUSON GC
MACMILLAN CH
SUGDEN EM
TALBOT DC
QUIGLEY IG
WEATHERSTONE RM
VEALE D
OREGAN PF
Citation: Dj. Girling et al., COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL, Lancet, 348(9027), 1996, pp. 563-566
Authors:
BLEEHEN NM
GIRLING DJ
HOPWOOD P
LALLEMAND G
MACHIN D
STEPHENS RJ
BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996), British Journal of Cancer, 74(6), 1996, pp. 997-997
Authors:
STEPHENS RJ
GIRLING DJ
BLEEHEN NM
MOGHISSI K
YOSEF HMA
MACHIN D
Citation: Rj. Stephens et al., THE ROLE OF POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED TRIAL IN PATIENTS WITH PATHOLOGICALLY STAGED T1-2N1-2,M(0) DISEASE, British Journal of Cancer, 74(4), 1996, pp. 632-639
Authors:
BLEEHEN NM
GIRLING DJ
HOPWOOD P
LALLEMAND G
MACHIN D
STEPHENS RJ
BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS, British Journal of Cancer, 73(3), 1996, pp. 406-413
Authors:
SWEETENHAM JW
SANTINI G
SIMNETT S
GIBSON D
GUELFI M
BRUZZI P
MACHIN D
GOLDSTONE AH
Citation: Jw. Sweetenham et al., CONVENTIONAL-DOSE VERSUS HIGH BOSE POSTREMISSION THERAPY FOR ADULTS WITH LYMPHOBLASTIC LYMPHOMA - A PROGRESS REPORT ON THE EBMT UKLG TRIAL ARID A PRELIMINARY-ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 88(10), 1996, pp. 484-484
Citation: Aw. Craft et al., ADJUVANT CHEMOTHERAPY FOR NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITIES IN 2 NEW-ZEALAND CANCER CENTERS, Australian and New Zealand Journal of Medicine, 26(2), 1996, pp. 230-230
Authors:
THATCHER N
ANDERSON H
BLEEHEN NI
GIRLING DJ
LALLEMAND G
MACHIN D
STEPHENS RJ
Citation: N. Thatcher et al., THE FEASIBILITY OF USING GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TO INCREASE THE PLANNED DOSE INTENSITY OF DOXORUBICIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE (ACE) IN THE TREATMENT OF SMALL-CELL LUNG-CANCER, European journal of cancer, 31A(2), 1995, pp. 152-156
Citation: T. Colton et al., INTERNATIONAL-SOCIETY-FOR-CLINICAL-BIOSTATISTICS 15TH INTERNATIONAL MEETING HELD AT THE CONVENTION CENTER BASEL 25-29 JULY 1994 - PREFACE, Statistics in medicine, 14(24), 1995, pp. 2625-2625